Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin.
Conclusion. Trihoney was able to maintain normal liver function and showed hepatoprotection against progression of NAFLD to NASH probably through hypocholesterolaemic and antioxidant functions.
PMID: 33132768 [PubMed - in process]
Source: The Scientific World Journal - Category: Science Tags: ScientificWorldJournal Source Type: research
More News: Antidoxidants | Atorvastatin Calcium | Bilirubin | Cholesterol | Diets | Fatty Liver Disease (FLD) | Lipitor | Liver | Liver Disease | New Zealand Health | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Science | Statin Therapy | Study | Urology & Nephrology | Zivast